Amerisourcebergen corp (ABC)
CashFlow / Yearly
Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07
OPERATING ACTIVITIES
Net income attributable to AmerisourceBergen Corporation shareholders

-

-

-

-

-138

274

433

718

706

636

503

250

469

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

854

1,615

364

1,427

-

-

-

-

-

-

-

-

-

Loss from discontinued operations

-

-

-

-

-

-7

-59

-42

9

9

-8

-

-5

Income (loss) from continuing operations

-

-

-

-

-

281

493

761

697

626

511

469

474

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, including amounts charged to cost of goods sold

321

318

262

232

193

165

138

113

89

67

74

75

76

Amortization, including amounts charged to interest expense

176

191

169

159

62

31

32

26

17

17

19

20

21

Provision for doubtful accounts

25

16

8

13

8

26

20

23

37

41

31

27

48

(Benefit) provision for deferred income taxes

28

-795

319

-130

20

38

25

61

194

83

84

62

11

Warrants expense

-

-

-

140

912

422

90

0

0

-

-

-

-

Share-based compensation

58

62

62

64

60

43

36

25

27

29

27

25

24

Inventory, LIFO Reserve, Period Charge

-22

67

-157

200

542

348

-

-

-

-

-

-

-

Impairment of PharMEDium assets

570

0

0

0

-

-

-

-

-

-

-

-

-

Gain on sale of an equity investment

13

0

0

-

-

-

-

-

-

-

-

-

-

Goodwill impairment

0

59

0

0

-

-

-

-

-

-

-

-

-

Impairment of non-customer note receivable

0

30

0

-

-

-

-

-

-

-

-

-

-

Loss on consolidation of equity investments

0

42

0

0

-

-

-

-

-

-

-

-

-

Impairment charge on equity investment

-

-

-

-

30

0

0

-

-

-

-

-

-

Loss on early retirement of debt

0

-23

0

0

-

-32

0

0

-

-

-

-

-

(Gain) loss on the sale of assets

-

-

-

-2

-

-

-

-

-

-

-

-

-

Gain on sale of business

-

-

-

0

-12

0

0

-

-

-

-

-

-

Pension settlement

-

-

-

-47

0

0

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-0

-8

-3

-5

-1

Other

23

19

-7

7

11

6

-3

9

-5

-9

13

1

5

Changes in operating assets and liabilities, excluding the effects of acquisitions:
Accounts receivable

1,241

657

1,277

912

1,478

938

2,312

-71

23

-62

457

-8

-236

Inventories

167

4

431

1,107

1,379

1,304

1,486

116

228

241

765

8

286

Prepaid expenses and other assets

6

57

-33

46

37

-21

169

-49

26

-10

15

16

-10

Accounts payable

1,561

859

1,473

3,011

4,957

2,255

-

-

-

-

-

-

-

Income taxes payable

-13

209

27

93

-

-

-

-

-

-

-

-

-

Accrued expenses and other liabilities

238

-551

642

-43

152

55

3,818

416

388

386

1,259

53

507

Other liabilities

-

-

-

33

12

-

12

-7

-3

-21

3

-5

-1

Net cash provided by operating activities-continuing operations

-

-

-

-

-

1,472

701

1,416

1,177

1,081

790

719

1,207

Net cash used in operating activities-discontinued operations

-

-

-

-

-

-7

86

-111

-9

27

-7

17

0

NET CASH PROVIDED BY OPERATING ACTIVITIES

2,344

1,411

1,504

3,178

3,922

1,464

788

1,305

1,167

1,108

783

737

1,207

INVESTING ACTIVITIES
Capital expenditures

310

336

466

464

231

264

202

133

156

175

145

137

111

Cost of acquired companies, net of cash acquired

63

785

61

2,731

2,633

9

0

775

45

0

13

169

86

Cost of equity investments

0

0

11

19

0

117

0

0

-

-

-

-

-

Proceeds from sales of property and equipment

-

-

-

-

-

-

-

-

0

0

0

3

8

Proceeds from sale of business

0

0

12

0

17

0

329

0

0

-

11

-

0

Proceeds from sales of investment securities available-for-sale

0

0

74

101

0

0

-

-

-

-

-

1,376

7,346

Purchases of investment securities available-for-sale

0

0

48

42

86

0

0

-

-

-

-

909

7,745

Other

1

-10

-3

13

-2

-7

-1

-0

-

-

-

-

-

Proceeds from sales of other assets

-

-

-

-

-

-

-

-

-

-

-

1

5

NET CASH USED IN INVESTING ACTIVITIES

-375

-1,111

-498

-3,169

-2,931

-384

117

-947

-212

-184

-148

163

-674

Net cash used in investing activities-discontinued operations

-

-

-

-

-

-

-11

-39

-11

-8

-1

-2

-90

NET CASH USED IN INVESTING ACTIVITIES

-

-

-

-

-

-

128

-908

-200

-175

-147

165

-583

FINANCING ACTIVITIES
Senior notes and other loan borrowings

506

1,314

0

1,000

1,996

1,097

0

499

0

396

0

-

-

Senior notes and other loan repayments

510

681

750

800

500

531

0

447

0

7

0

-

-

Borrowings under revolving and securitization credit facilities

640

25,129

9,336

8,846

111

17,584

2,330

60

35

2

2,153

5,956

722

Repayments under revolving and securitization credit facilities

769

25,127

9,335

8,333

111

17,584

2,330

60

35

37

2,162

5,972

621

Payment for Debt Extinguishment or Debt Prepayment Cost

0

22

0

0

-

-

-

-

-

-

-

-

-

Proceeds from borrowing related to PharMerica Long-Term Care distribution

-

-

-

-

-

-

-

-

-

-

-

-

125

Purchases of common stock

674

639

329

2,266

1,859

753

484

1,162

840

470

450

679

1,434

Exercises of warrants

-

-

-

2,360

0

0

-

-

-

-

-

-

-

Exercises of stock options

76

138

102

74

193

127

155

115

155

132

22

84

94

Cash dividends on common stock

338

333

320

288

253

214

195

132

117

90

62

48

37

Purchases of call options

-

-

-

-

180

211

157

0

0

-

-

-

-

Tax withholdings related to restricted share vesting

5

8

9

22

14

-

-

-

-

-

-

-

-

Other

-10

-14

-6

-6

-14

-17

-8

-10

-7

-9

-4

-2

-4

NET CASH USED IN FINANCING ACTIVITIES

-1,086

-242

-1,312

565

-632

-502

-740

-1,116

-787

-275

-504

-662

-1,154

Net cash used in financing activities-discontinued operations

-

-

-

-

-

-

-50

21

22

-191

-

-0

0

NET CASH PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

-

-

-690

-1,138

-810

-83

-

-662

-1,154

INCREASE IN CASH AND CASH EQUIVALENTS

881

57

-306

574

358

577

164

-759

167

648

131

237

-621